White House manufacturing policy advisor Peter Navarro has an important discussion with Maria Bartiromo about the consequences of the Coronavirus which includes the need for U.S. companies to return manufacturing to the United States on key medical products and pharmaceuticals. A very important subject.
Both Navarro and Bartiromo note that our dependency on Asia for medical products is a problem when a global virus erupts, global demand for those products peaks, and the supply of those products becomes most urgent.
It would seem obvious (to me) that medical products and pharmaceuticals would be two sectors for the Commerce Department (Sec. Wilbur Ross) where a national security review would be well worth the time & effort. The multinationals would fight the administration, but it might be worth this fight.